US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alkermes PLC

47.20

-0.0050-0.01%

Volume:421.80K

Turnover:19.98M

Market Cap:7.92B

PE:121.56

High:48.73

Open:47.70

Low:46.71

Close:47.20

52wk High:55.67

52wk Low:25.17

Shares:167.76M

Float Shares:155.00M

Volume Ratio:0.47

T/O Rate:0.27%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.3882

EPS(LYR):1.43

ROE:3.85%

ROA:4.20%

PB:4.38

PE(LYR):33.00

Loading ...

Overview Company News Filings

Alkermes (ALKS) Stock Valuation After New Orphan Drug Designation For Alixorexton

Simply Wall St.

Alkermes director Christopher I. Wright disposes of USD 90,200 in common shares

Should Alkermes’ (ALKS) Sleep-Medicine Pivot After Lumryz and Alixorexton Data Require Investor Action?

Simply Wall St.

Alkermes’ alixorexton granted orphan designation for idiopathic hypersomnia

Mizuho Securities Sticks to Their Buy Rating for Alkermes (ALKS)

Alkermes' Orexin May Have Applicability Outside Sleep, RBC Says

MT Newswires Live

RBC Raises Price Target on Alkermes to $56 From $45, Keeps Outperform Rating

MT Newswires Live

Alkermes Plc : RBC Raises Target Price to $56 From $45

THOMSON REUTERS

Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)

A Look At Alkermes (ALKS) Valuation After 28.2% Revenue Growth And Strengthening Analyst Optimism

Simply Wall St.

Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $87,569.7

Alkermes to present new data on Alixorexton, LUMRYZ

Alkermes presents new phase 2 Vibrance-2 data for alixorexton in narcolepsy type 2 at SLEEP 2026

Mizuho Securities Reaffirms Their Buy Rating on Alkermes (ALKS)

Alkermes to join Goldman Sachs Global Healthcare Conference fireside chat

Is Alkermes’ (ALKS) New LYBALVI Real-World Data Quietly Reframing Its Psychiatry Investment Story?

Simply Wall St.

Alkermes Chief Medical Officer Craig Hopkinson sells 9,000 shares for $375,044‬

Alkermes VP Finance Samuel Joseph Parisi disposes of 16,217 shares for $686,807.86

Needham Reiterates Buy Rating on Alkermes as Preclinical ALKS 7290 Data Support Unchanged $50 Price Target

Alkermes presents Phase 2 Vibrance-1 data on alixorexton in narcolepsy type 1 at ASCP meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://au1.tigerplaytime.com/stock/ALKS/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALKS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","market":"US","secType":"STK","nameCN":"Alkermes PLC","latestPrice":47.195,"timestamp":1788370886689,"preClose":47.2,"halted":0,"volume":421802,"delay":0,"changeRate":-0.0001059322033898847,"floatShares":155000000,"shares":167763272,"eps":0.388236,"marketStatus":"Trading","change":-0.005,"latestTime":"09-02 13:41:35 EDT","open":47.7,"high":48.725,"low":46.71,"amount":19975300.934912,"amplitude":0.042691,"askPrice":47.23,"askSize":112,"bidPrice":47.17,"bidSize":139,"shortable":3,"etf":0,"ttmEps":0.388236,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1788379200000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":47.2,"preHourTrading":{"tag":"盘前","latestPrice":47.76,"preClose":47.2,"latestTime":"09:28 EDT","volume":2107,"amount":99454.02404,"timestamp":1788355732073,"change":0.56,"changeRate":0.011864,"amplitude":0.022246},"postHourTrading":{"tag":"盘后","latestPrice":47.2,"preClose":47.2,"latestTime":"19:30 EDT","volume":193868,"amount":9150569.18,"timestamp":1788305400471,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.466164,"impliedVol":0.5708,"impliedVolPercentile":0.7937},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALKS\",,,,,undefined,":{"symbol":"ALKS","floatShares":155000000,"roa":"4.20%","roe":"3.85%","lyrEps":1.43,"volumeRatio":0.466164,"shares":167763272,"dividePrice":0,"high":48.725,"amplitude":0.042691,"preClose":47.2,"low":46.71,"week52Low":25.165,"pbRate":"4.38","psRate":"4.75","week52High":55.67,"institutionHeld":0.9671,"latestPrice":47.195,"committee":0.10757,"eps":0.388236,"divideRate":0,"volume":421802,"delay":0,"ttmEps":0.388236,"open":47.7,"prevYearClose":27.98,"prevWeekClose":47.41,"prevMonthClose":46.99,"prevQuarterClose":52.395,"fiveDayClose":49.16,"twentyDayClose":49.61,"sixtyDayClose":42.45,"dividendPayoutRate":0,"dividendGrowthYears":0,"fiveYearAvgDividendRate":0},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALKS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-07-28","symbol":"ALKS","fiscalQuarterEnding":"2026/06","expectedEps":-0.04,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785211200000,"reportTimeType":"pre","actualEps":0},{"market":"US","date":"2026-05-05","symbol":"ALKS","fiscalQuarterEnding":"2026/03","expectedEps":-0.57,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1777953600000,"reportTimeType":"pre","actualEps":-0.4},{"market":"US","date":"2026-02-25","symbol":"ALKS","fiscalQuarterEnding":"2025/12","expectedEps":0.31,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"pre","actualEps":0.34},{"market":"US","date":"2026-01-12","symbol":"ALKS","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1768194000000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-10-28","symbol":"ALKS","fiscalQuarterEnding":"2025/09","expectedEps":0.34,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.49}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALKS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALKS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2105,"buy":0.5263,"hold":0.2105,"sell":0.0526,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5263,"analysts":19,"updateTime":1784606400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALKS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALKS","date":"2026-09-01","current":121.562658,"percent":0.980738,"low":-99.853332,"twenty":-40.481017,"median":13.431577,"eighty":18.870166,"high":128.125542,"avg":-4.483191,"sd":42.305404,"marketCap":7883196151},"quantilePoints":[{"date":"2021-09-03","current":-76.672915,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4817359246},{"date":"2021-09-10","current":-78.367628,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4923838051},{"date":"2021-09-17","current":-77.314852,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4857692127},{"date":"2021-09-24","current":-82.373313,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5175515225},{"date":"2021-10-01","current":-79.292017,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4981917399},{"date":"2021-10-08","current":-81.397569,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5114209247},{"date":"2021-10-15","current":-81.320536,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":5109369301},{"date":"2021-10-22","current":-79.214984,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4977077453},{"date":"2021-10-29","current":-53.423232,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4898055566},{"date":"2021-11-05","current":-53.493781,"twenty":-50.264255,"median":-35.906358,"eighty":-20.409777,"marketCap":4904523781},{"date":"2021-11-12","current":-42.294127,"twenty":-50.154251,"median":-35.906358,"eighty":-20.409777,"marketCap":3877694700},{"date":"2021-11-19","current":-40.98897,"twenty":-49.694628,"median":-35.906358,"eighty":-20.409777,"marketCap":3758032729},{"date":"2021-11-26","current":-39.630902,"twenty":-49.492729,"median":-35.906358,"eighty":-20.409777,"marketCap":3633519596},{"date":"2021-12-03","current":-38.8725,"twenty":-49.409499,"median":-35.906358,"eighty":-20.409777,"marketCap":3563986288},{"date":"2021-12-10","current":-38.502118,"twenty":-49.260842,"median":-35.906358,"eighty":-20.409777,"marketCap":3530028161},{"date":"2021-12-17","current":-41.200617,"twenty":-48.983435,"median":-35.906358,"eighty":-20.409777,"marketCap":3777437373},{"date":"2021-12-23","current":-42.488136,"twenty":-48.911898,"median":-35.906358,"eighty":-20.409777,"marketCap":3895482291},{"date":"2021-12-31","current":-41.024245,"twenty":-48.71686,"median":-35.906358,"eighty":-20.409777,"marketCap":3761266836},{"date":"2022-01-07","current":-42.347038,"twenty":-48.396814,"median":-35.934227,"eighty":-20.409786,"marketCap":3882545861},{"date":"2022-01-14","current":-44.534057,"twenty":-48.237657,"median":-35.934227,"eighty":-20.409786,"marketCap":4083060516},{"date":"2022-01-21","current":-42.329401,"twenty":-48.134628,"median":-35.934227,"eighty":-20.409786,"marketCap":3880928808},{"date":"2022-01-28","current":-44.234224,"twenty":-47.856145,"median":-35.934227,"eighty":-20.409786,"marketCap":4055570604},{"date":"2022-02-04","current":-41.817921,"twenty":-47.644696,"median":-35.934227,"eighty":-20.409786,"marketCap":3834034251},{"date":"2022-02-11","current":-40.918421,"twenty":-47.524593,"median":-35.934227,"eighty":-20.409786,"marketCap":3751564514},{"date":"2022-02-18","current":-84.332018,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4062188990},{"date":"2022-02-25","current":-83.424138,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4018457290},{"date":"2022-03-04","current":-77.943229,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3754447400},{"date":"2022-03-11","current":-81.978254,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":3948810510},{"date":"2022-03-18","current":-87.82904,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4230637018},{"date":"2022-03-25","current":-92.233942,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4442816746},{"date":"2022-04-01","current":-94.35233,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4544857379},{"date":"2022-04-08","current":-99.631487,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4799149114},{"date":"2022-04-14","current":-98.723607,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4755417414},{"date":"2022-04-22","current":-95.615075,"twenty":-47.3542,"median":-35.934227,"eighty":-20.409786,"marketCap":4605682543},{"date":"2022-04-29","current":-76.473016,"twenty":-47.524593,"median":-36.079146,"eighty":-20.409786,"marketCap":4714867305},{"date":"2022-05-06","current":-73.239148,"twenty":-47.644696,"median":-36.311039,"eighty":-20.409786,"marketCap":4515486435},{"date":"2022-05-13","current":-71.251115,"twenty":-47.856145,"median":-36.514549,"eighty":-20.409786,"marketCap":4392916227},{"date":"2022-05-20","current":-79.521333,"twenty":-48.134628,"median":-36.669968,"eighty":-20.409786,"marketCap":4902808290},{"date":"2022-05-27","current":-80.952717,"twenty":-48.282786,"median":-36.809313,"eighty":-20.409786,"marketCap":4991058839},{"date":"2022-06-03","current":-77.692343,"twenty":-48.396814,"median":-36.895372,"eighty":-20.409786,"marketCap":4790043699},{"date":"2022-06-10","current":-73.104657,"twenty":-48.753891,"median":-37.077955,"eighty":-20.409786,"marketCap":4507194550},{"date":"2022-06-17","current":-74.622125,"twenty":-48.950091,"median":-37.212055,"eighty":-20.409786,"marketCap":4600752485},{"date":"2022-06-24","current":-79.09466,"twenty":-49.022902,"median":-37.321505,"eighty":-20.409777,"marketCap":4876502188},{"date":"2022-07-01","current":-81.277684,"twenty":-49.282838,"median":-37.389331,"eighty":-20.409777,"marketCap":5011094305},{"date":"2022-07-08","current":-84.791819,"twenty":-49.409499,"median":-37.46584,"eighty":-20.409777,"marketCap":5227754786},{"date":"2022-07-15","current":-79.68035,"twenty":-49.492729,"median":-37.601025,"eighty":-20.409777,"marketCap":4912612269},{"date":"2022-07-22","current":-76.725281,"twenty":-49.769136,"median":-37.711507,"eighty":-20.409777,"marketCap":4730420500},{"date":"2022-07-29","current":-44.659913,"twenty":-50.043112,"median":-37.815476,"eighty":-20.409777,"marketCap":4204909440},{"date":"2022-08-05","current":-44.956483,"twenty":-50.043112,"median":-37.914647,"eighty":-20.409777,"marketCap":4232832666},{"date":"2022-08-12","current":-45.619403,"twenty":-50.043112,"median":-38.002104,"eighty":-20.409777,"marketCap":4295249291},{"date":"2022-08-19","current":-44.066773,"twenty":-50.043112,"median":-38.10506,"eighty":-20.409777,"marketCap":4149062986},{"date":"2022-08-26","current":-42.810713,"twenty":-50.043112,"median":-38.291941,"eighty":-20.409777,"marketCap":4030799908},{"date":"2022-09-02","current":-42.758378,"twenty":-50.043112,"median":-38.448007,"eighty":-20.409777,"marketCap":4025872280},{"date":"2022-09-09","current":-41.886114,"twenty":-50.043112,"median":-38.5362,"eighty":-20.409777,"marketCap":3943745142},{"date":"2022-09-16","current":-40.769616,"twenty":-50.043112,"median":-38.660853,"eighty":-20.409777,"marketCap":3838622406},{"date":"2022-09-23","current":-38.937862,"twenty":-50.043112,"median":-38.765906,"eighty":-20.409777,"marketCap":3666155418},{"date":"2022-09-30","current":-38.955307,"twenty":-50.043112,"median":-38.937862,"eighty":-20.409777,"marketCap":3667797960},{"date":"2022-10-07","current":-38.606401,"twenty":-50.043112,"median":-39.109838,"eighty":-20.409777,"marketCap":3634947105},{"date":"2022-10-14","current":-39.46122,"twenty":-50.043112,"median":-39.133049,"eighty":-20.409777,"marketCap":3715431700},{"date":"2022-10-21","current":-38.83319,"twenty":-50.043112,"median":-39.135862,"eighty":-20.409777,"marketCap":3656300161},{"date":"2022-10-28","current":-40.699835,"twenty":-50.043112,"median":-39.199541,"eighty":-20.409777,"marketCap":3832052235},{"date":"2022-11-04","current":-30.511153,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3940210296},{"date":"2022-11-11","current":-30.014933,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3876128478},{"date":"2022-11-18","current":-29.824079,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3851481624},{"date":"2022-11-25","current":-30.791072,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":3976359015},{"date":"2022-12-02","current":-33.195829,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4286909368},{"date":"2022-12-09","current":-31.427251,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4058515193},{"date":"2022-12-16","current":-32.470585,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4193251325},{"date":"2022-12-23","current":-32.432414,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4188321954},{"date":"2022-12-30","current":-33.246723,"twenty":-50.043112,"median":-39.213937,"eighty":-20.409777,"marketCap":4293481862},{"date":"2023-01-06","current":-34.493635,"twenty":-49.769136,"median":-39.154696,"eighty":-20.409777,"marketCap":4454507971},{"date":"2023-01-13","current":-34.748106,"twenty":-49.492729,"median":-39.12976,"eighty":-20.409777,"marketCap":4487370442},{"date":"2023-01-20","current":-35.269773,"twenty":-49.420616,"median":-39.023312,"eighty":-20.409777,"marketCap":4554738508},{"date":"2023-01-27","current":-36.923839,"twenty":-49.282838,"median":-38.850635,"eighty":-20.409777,"marketCap":4768344571},{"date":"2023-02-03","current":-34.799001,"twenty":-48.983435,"median":-38.742102,"eighty":-20.409777,"marketCap":4493942936},{"date":"2023-02-10","current":-34.468187,"twenty":-48.9133,"median":-38.606401,"eighty":-20.409777,"marketCap":4451221724},{"date":"2023-02-17","current":-29.155811,"twenty":-48.645431,"median":-38.5362,"eighty":-20.409777,"marketCap":4614402682},{"date":"2023-02-24","current":-28.231383,"twenty":-48.351507,"median":-38.448007,"eighty":-20.409777,"marketCap":4468096363},{"date":"2023-03-03","current":-28.304091,"twenty":-48.220837,"median":-38.373879,"eighty":-20.409777,"marketCap":4479603601},{"date":"2023-03-10","current":-27.639335,"twenty":-48.116754,"median":-38.274941,"eighty":-20.409777,"marketCap":4374394563},{"date":"2023-03-17","current":-27.036899,"twenty":-47.811464,"median":-38.093155,"eighty":-20.409777,"marketCap":4279048871},{"date":"2023-03-24","current":-27.514693,"twenty":-47.598057,"median":-37.993052,"eighty":-20.409777,"marketCap":4354667868},{"date":"2023-03-31","current":-29.280453,"twenty":-47.463781,"median":-37.913785,"eighty":-20.409786,"marketCap":4634129377},{"date":"2023-04-06","current":-30.506098,"twenty":-47.463781,"median":-37.82284,"eighty":-20.409786,"marketCap":4828108542},{"date":"2023-04-14","current":-31.035826,"twenty":-47.475869,"median":-37.711507,"eighty":-20.409777,"marketCap":4911946995},{"date":"2023-04-21","current":-30.121785,"twenty":-47.475869,"median":-37.601025,"eighty":-20.409777,"marketCap":4767284567},{"date":"2023-04-28","current":-28.670049,"twenty":-47.475869,"median":-37.46584,"eighty":-20.409777,"marketCap":4707880022},{"date":"2023-05-05","current":-29.044358,"twenty":-47.475869,"median":-37.38821,"eighty":-20.409777,"marketCap":4769344934},{"date":"2023-05-12","current":-31.543123,"twenty":-47.378573,"median":-37.313027,"eighty":-20.409777,"marketCap":5179664753},{"date":"2023-05-19","current":-30.531477,"twenty":-47.214893,"median":-37.152993,"eighty":-20.409777,"marketCap":5013543369},{"date":"2023-05-26","current":-29.722161,"twenty":-47.214893,"median":-36.987674,"eighty":-20.409777,"marketCap":4880646261},{"date":"2023-06-02","current":-29.620996,"twenty":-47.130816,"median":-36.919193,"eighty":-20.409767,"marketCap":4864034123},{"date":"2023-06-09","current":-31.907316,"twenty":-46.901522,"median":-36.809313,"eighty":-20.409767,"marketCap":5239468451},{"date":"2023-06-16","current":-32.301858,"twenty":-46.574329,"median":-36.669968,"eighty":-20.409767,"marketCap":5304255791},{"date":"2023-06-23","current":-34.021656,"twenty":-46.462045,"median":-36.564066,"eighty":-20.409758,"marketCap":5586662143},{"date":"2023-06-30","current":-31.69487,"twenty":-46.464564,"median":-36.443843,"eighty":-20.409749,"marketCap":5204582960},{"date":"2023-07-07","current":-30.399963,"twenty":-46.464564,"median":-36.324905,"eighty":-20.409749,"marketCap":4991947589},{"date":"2023-07-14","current":-30.359498,"twenty":-46.464564,"median":-36.212917,"eighty":-20.409749,"marketCap":4985302733},{"date":"2023-07-21","current":-32.342324,"twenty":-46.464564,"median":-35.934227,"eighty":-20.409749,"marketCap":5310900646},{"date":"2023-07-28","current":48.950981,"twenty":-46.442933,"median":-35.452039,"eighty":-20.368741,"marketCap":5041559440},{"date":"2023-08-04","current":44.683255,"twenty":-46.317214,"median":-35.211157,"eighty":-20.301088,"marketCap":4602017848},{"date":"2023-08-11","current":44.87732,"twenty":-45.967039,"median":-35.023652,"eighty":-20.120159,"marketCap":4622004896},{"date":"2023-08-18","current":46.446004,"twenty":-45.664437,"median":-34.69182,"eighty":-19.956848,"marketCap":4783566869},{"date":"2023-08-25","current":44.570051,"twenty":-45.404618,"median":-34.474549,"eighty":-19.830023,"marketCap":4590358736},{"date":"2023-09-01","current":47.206089,"twenty":-44.974989,"median":-34.130848,"eighty":-19.651548,"marketCap":4861849474},{"date":"2023-09-08","current":47.206089,"twenty":-44.907093,"median":-33.585511,"eighty":-19.51296,"marketCap":4861849474},{"date":"2023-09-15","current":48.273441,"twenty":-44.907093,"median":-33.253085,"eighty":-19.271435,"marketCap":4971778239},{"date":"2023-09-22","current":48.047033,"twenty":-44.802128,"median":-33.04036,"eighty":-19.191423,"marketCap":4948460016},{"date":"2023-09-29","current":45.540372,"twenty":-44.659913,"median":-32.766368,"eighty":-19.065691,"marketCap":4690293977},{"date":"2023-10-06","current":45.993188,"twenty":-44.528541,"median":-32.483308,"eighty":-18.951388,"marketCap":4736930423},{"date":"2023-10-13","current":44.262783,"twenty":-44.236515,"median":-32.381007,"eighty":-18.699922,"marketCap":4558712576},{"date":"2023-10-20","current":43.357151,"twenty":-44.110763,"median":-32.257067,"eighty":-18.558361,"marketCap":4465439685},{"date":"2023-10-27","current":19.196586,"twenty":-44.052817,"median":-32.165219,"eighty":-18.485448,"marketCap":4121967764},{"date":"2023-11-03","current":19.080008,"twenty":-43.835622,"median":-32.114324,"eighty":-18.329394,"marketCap":4096935571},{"date":"2023-11-10","current":19.04892,"twenty":-43.835622,"median":-31.907316,"eighty":-18.128571,"marketCap":4090260319},{"date":"2023-11-17","current":18.162924,"twenty":-43.835622,"median":-31.735336,"eighty":-17.870084,"marketCap":3900015653},{"date":"2023-11-24","current":18.955657,"twenty":-43.835622,"median":-31.583589,"eighty":-17.644018,"marketCap":4070234565},{"date":"2023-12-01","current":18.76136,"twenty":-43.835622,"median":-31.427251,"eighty":-17.293018,"marketCap":4028514244},{"date":"2023-12-08","current":20.331283,"twenty":-43.821513,"median":-31.320561,"eighty":-17.111515,"marketCap":4365614441},{"date":"2023-12-15","current":20.945263,"twenty":-43.821513,"median":-30.985981,"eighty":-16.974211,"marketCap":4497450657},{"date":"2023-12-22","current":21.411577,"twenty":-43.821513,"median":-30.840029,"eighty":-16.775651,"marketCap":4597579429},{"date":"2023-12-29","current":21.668049,"twenty":-43.835622,"median":-30.75404,"eighty":-16.674022,"marketCap":4652650253},{"date":"2024-01-05","current":22.250942,"twenty":-43.849732,"median":-30.587118,"eighty":-16.545483,"marketCap":4777811218},{"date":"2024-01-12","current":21.714681,"twenty":-43.849732,"median":-30.537472,"eighty":-16.468673,"marketCap":4662663130},{"date":"2024-01-19","current":21.574787,"twenty":-43.863842,"median":-30.498429,"eighty":-16.419138,"marketCap":4632624499},{"date":"2024-01-26","current":21.776856,"twenty":-43.849732,"median":-30.390709,"eighty":-16.359531,"marketCap":4676013633},{"date":"2024-02-02","current":20.937491,"twenty":-43.849732,"median":-30.268366,"eighty":-16.245798,"marketCap":4495781844},{"date":"2024-02-09","current":20.805369,"twenty":-43.849732,"median":-30.124302,"eighty":-16.099824,"marketCap":4467412026},{"date":"2024-02-16","current":15.282535,"twenty":-43.849732,"median":-30.000061,"eighty":-15.989003,"marketCap":5436868800},{"date":"2024-02-23","current":13.569352,"twenty":-43.849732,"median":-29.813586,"eighty":-15.868185,"marketCap":4827391800},{"date":"2024-03-01","current":13.943479,"twenty":-43.835622,"median":-29.691811,"eighty":-15.810302,"marketCap":4960490388},{"date":"2024-03-08","current":13.830767,"twenty":-43.835622,"median":-29.445673,"eighty":-15.761184,"marketCap":4920392116},{"date":"2024-03-15","current":13.563075,"twenty":-43.835622,"median":-29.155811,"eighty":-15.689068,"marketCap":4825158721},{"date":"2024-03-22","current":12.666071,"twenty":-43.835622,"median":-28.997047,"eighty":-15.65825,"marketCap":4506043307},{"date":"2024-03-28","current":12.797569,"twenty":-43.835622,"median":-28.957305,"eighty":-15.60417,"marketCap":4552824624},{"date":"2024-04-05","current":12.121293,"twenty":-43.849732,"median":-28.827848,"eighty":-15.449766,"marketCap":4312234992},{"date":"2024-04-12","current":11.884271,"twenty":-43.849732,"median":-28.713822,"eighty":-15.310254,"marketCap":4227912733},{"date":"2024-04-19","current":11.299331,"twenty":-43.849732,"median":-28.508069,"eighty":-15.24785,"marketCap":4019816188},{"date":"2024-04-26","current":11.622713,"twenty":-43.835622,"median":-28.43912,"eighty":-15.200526,"marketCap":4134861432},{"date":"2024-05-03","current":9.294065,"twenty":-43.835622,"median":-28.43912,"eighty":-15.01869,"marketCap":4037620480},{"date":"2024-05-10","current":9.449875,"twenty":-43.835622,"median":-28.43912,"eighty":-14.970096,"marketCap":4105309004},{"date":"2024-05-17","current":9.52778,"twenty":-43.835622,"median":-28.43912,"eighty":-14.582911,"marketCap":4139153267},{"date":"2024-05-24","current":9.348598,"twenty":-43.835622,"median":-28.43912,"eighty":-14.167324,"marketCap":4061311464},{"date":"2024-05-31","current":9.114883,"twenty":-43.835622,"median":-28.43912,"eighty":-13.940216,"marketCap":3959778677},{"date":"2024-06-07","current":9.313541,"twenty":-43.835622,"median":-28.43912,"eighty":-13.607896,"marketCap":4046081546},{"date":"2024-06-14","current":9.543361,"twenty":-43.835622,"median":-28.43912,"eighty":-13.123801,"marketCap":4145922119},{"date":"2024-06-21","current":9.718647,"twenty":-43.849732,"median":-28.439666,"eighty":-12.956146,"marketCap":4222071709},{"date":"2024-06-28","current":9.387551,"twenty":-43.849732,"median":-28.439666,"eighty":-12.533786,"marketCap":4078233595},{"date":"2024-07-05","current":9.46156,"twenty":-43.849732,"median":-28.439666,"eighty":-12.248451,"marketCap":4110385644},{"date":"2024-07-12","current":9.181102,"twenty":-43.849732,"median":-28.439666,"eighty":-11.555991,"marketCap":3988546300},{"date":"2024-07-19","current":9.671904,"twenty":-43.849732,"median":-28.439666,"eighty":-11.295982,"marketCap":4201765152},{"date":"2024-07-26","current":15.900891,"twenty":-43.849732,"median":-28.439666,"eighty":-10.747072,"marketCap":4590953012},{"date":"2024-08-02","current":15.809638,"twenty":-43.849732,"median":-28.439666,"eighty":9.065803,"marketCap":4564606079},{"date":"2024-08-09","current":14.868588,"twenty":-43.849732,"median":-28.439666,"eighty":9.206032,"marketCap":4292903337},{"date":"2024-08-16","current":15.541581,"twenty":-43.849732,"median":-28.439666,"eighty":9.350072,"marketCap":4487211965},{"date":"2024-08-23","current":15.940815,"twenty":-43.849732,"median":-28.439666,"eighty":9.384045,"marketCap":4602479795},{"date":"2024-08-30","current":16.225981,"twenty":-43.849732,"median":-28.439666,"eighty":9.410143,"marketCap":4684813960},{"date":"2024-09-06","current":15.319151,"twenty":-43.849732,"median":-28.439666,"eighty":9.422608,"marketCap":4422991316},{"date":"2024-09-13","current":15.775418,"twenty":-43.849732,"median":-28.439666,"eighty":9.46156,"marketCap":4554725980},{"date":"2024-09-20","current":16.283014,"twenty":-43.849732,"median":-28.439666,"eighty":9.509862,"marketCap":4701280792},{"date":"2024-09-27","current":15.701275,"twenty":-43.849732,"median":-28.439666,"eighty":9.56787,"marketCap":4533319097},{"date":"2024-10-04","current":16.522554,"twenty":-43.849732,"median":-28.439666,"eighty":9.600231,"marketCap":4770441491},{"date":"2024-10-11","current":16.488334,"twenty":-43.849732,"median":-28.439666,"eighty":9.670346,"marketCap":4760561391},{"date":"2024-10-18","current":16.123321,"twenty":-43.849732,"median":-28.439666,"eighty":9.754483,"marketCap":4655173660},{"date":"2024-10-25","current":12.663801,"twenty":-43.849732,"median":-28.439666,"eighty":11.422026,"marketCap":4221427433},{"date":"2024-11-01","current":12.848249,"twenty":-43.849732,"median":-28.439666,"eighty":11.702607,"marketCap":4282912386},{"date":"2024-11-08","current":14.008329,"twenty":-43.849732,"median":-28.439666,"eighty":12.289298,"marketCap":4669620380},{"date":"2024-11-15","current":13.683118,"twenty":-43.849732,"median":-28.439666,"eighty":12.552615,"marketCap":4561212700},{"date":"2024-11-22","current":13.969498,"twenty":-43.849732,"median":-28.439666,"eighty":12.712777,"marketCap":4656676180},{"date":"2024-11-29","current":14.085991,"twenty":-43.849732,"median":-28.439666,"eighty":12.812597,"marketCap":4695508782},{"date":"2024-12-06","current":15.27034,"twenty":-43.849732,"median":-28.439666,"eighty":12.900671,"marketCap":5090306901},{"date":"2024-12-13","current":14.809221,"twenty":-43.849732,"median":-28.439666,"eighty":13.110355,"marketCap":4936594519},{"date":"2024-12-20","current":14.42091,"twenty":-43.849732,"median":-28.439666,"eighty":13.442537,"marketCap":4807152512},{"date":"2024-12-27","current":14.343247,"twenty":-43.849732,"median":-28.439666,"eighty":13.559902,"marketCap":4781264111},{"date":"2025-01-03","current":14.095699,"twenty":-43.849732,"median":-28.439666,"eighty":13.693488,"marketCap":4698744832},{"date":"2025-01-10","current":13.629725,"twenty":-43.863842,"median":-28.440211,"eighty":13.770488,"marketCap":4543414424},{"date":"2025-01-17","current":14.304416,"twenty":-43.863842,"median":-28.440211,"eighty":13.833589,"marketCap":4768319910},{"date":"2025-01-24","current":15.139285,"twenty":-43.863842,"median":-28.440211,"eighty":13.948176,"marketCap":5046620224},{"date":"2025-01-31","current":15.304318,"twenty":-43.863842,"median":-28.440211,"eighty":13.976354,"marketCap":5101633077},{"date":"2025-02-07","current":15.323733,"twenty":-43.863842,"median":-28.440211,"eighty":14.085991,"marketCap":5108105177},{"date":"2025-02-14","current":15.899471,"twenty":-43.863842,"median":-28.440211,"eighty":14.192777,"marketCap":5836218864},{"date":"2025-02-21","current":15.646958,"twenty":-43.863842,"median":-28.440211,"eighty":14.231608,"marketCap":5743528846},{"date":"2025-02-28","current":15.208382,"twenty":-43.863842,"median":-28.440211,"eighty":14.30927,"marketCap":5582540920},{"date":"2025-03-07","current":15.217242,"twenty":-43.873027,"median":-28.454574,"eighty":14.44615,"marketCap":5585793201},{"date":"2025-03-14","current":15.075481,"twenty":-43.873027,"median":-28.454574,"eighty":14.62089,"marketCap":5533756700},{"date":"2025-03-21","current":15.327994,"twenty":-43.873027,"median":-28.454574,"eighty":14.815514,"marketCap":5626446718},{"date":"2025-03-28","current":14.913262,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5474211098},{"date":"2025-04-04","current":13.498725,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4954976983},{"date":"2025-04-11","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-17","current":12.124603,"twenty":-43.863842,"median":-28.440211,"eighty":14.886883,"marketCap":4450578129},{"date":"2025-04-25","current":12.501813,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4589040559},{"date":"2025-05-02","current":14.858162,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5240562837},{"date":"2025-05-09","current":14.086734,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4968475717},{"date":"2025-05-16","current":14.68985,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5181198374},{"date":"2025-05-23","current":14.049332,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4955283614},{"date":"2025-05-30","current":14.142838,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":4988263871},{"date":"2025-06-06","current":14.493487,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5111939835},{"date":"2025-06-13","current":14.39063,"twenty":-43.873027,"median":-28.454574,"eighty":14.888276,"marketCap":5075661552},{"date":"2025-06-20","current":13.712709,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4836554689},{"date":"2025-06-27","current":13.478943,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4754104046},{"date":"2025-07-03","current":13.488294,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4757402072},{"date":"2025-07-11","current":14.24102,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5022893141},{"date":"2025-07-18","current":13.726735,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4841501727},{"date":"2025-07-25","current":12.40362,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4374831091},{"date":"2025-08-01","current":12.549766,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4372915663},{"date":"2025-08-08","current":12.59951,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4390248851},{"date":"2025-08-15","current":13.388312,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4665103686},{"date":"2025-08-22","current":13.767316,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4797166069},{"date":"2025-08-29","current":13.705728,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4775705932},{"date":"2025-09-05","current":13.70099,"twenty":-43.891396,"median":-28.472159,"eighty":14.891062,"marketCap":4774055152},{"date":"2025-09-12","current":13.127747,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4574310798},{"date":"2025-09-19","current":13.525701,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4712976300},{"date":"2025-09-26","current":12.852969,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":4478565570},{"date":"2025-10-03","current":14.809576,"twenty":-43.882212,"median":-28.468938,"eighty":14.889669,"marketCap":5160337623},{"date":"2025-10-10","current":14.866427,"twenty":-43.882212,"median":-28.468938,"eighty":14.901614,"marketCap":5180146981},{"date":"2025-10-17","current":14.591649,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":5084401753},{"date":"2025-10-24","current":14.231595,"twenty":-43.882212,"median":-28.468938,"eighty":14.926634,"marketCap":4958942489},{"date":"2025-10-31","current":15.019277,"twenty":-43.882212,"median":-28.43912,"eighty":15.006893,"marketCap":5088921627},{"date":"2025-11-07","current":15.438375,"twenty":-43.882212,"median":-28.345638,"eighty":15.018474,"marketCap":5230922685},{"date":"2025-11-14","current":15.111868,"twenty":-43.882212,"median":-28.24177,"eighty":15.075763,"marketCap":5120293954},{"date":"2025-11-21","current":13.737619,"twenty":-43.882212,"median":-28.181663,"eighty":15.075763,"marketCap":4654662578},{"date":"2025-11-28","current":14.414997,"twenty":-43.882212,"median":-28.038026,"eighty":15.075763,"marketCap":4884175916},{"date":"2025-12-05","current":14.278547,"twenty":-43.882212,"median":-27.899005,"eighty":15.075763,"marketCap":4837943013},{"date":"2025-12-12","current":14.215195,"twenty":-43.674768,"median":-27.712042,"eighty":15.075763,"marketCap":4816477737},{"date":"2025-12-19","current":13.552437,"twenty":-43.352661,"median":-27.649721,"eighty":15.075763,"marketCap":4591917925},{"date":"2025-12-26","current":13.898436,"twenty":-43.181925,"median":-27.578386,"eighty":15.075763,"marketCap":4709151356},{"date":"2026-01-02","current":13.635282,"twenty":-42.896368,"median":-27.514693,"eighty":15.075763,"marketCap":4619987901},{"date":"2026-01-09","current":14.424744,"twenty":-42.786484,"median":-27.36293,"eighty":15.075763,"marketCap":4887478266},{"date":"2026-01-16","current":15.214206,"twenty":-42.614728,"median":-26.975109,"eighty":15.077555,"marketCap":5154968630},{"date":"2026-01-23","current":16.544596,"twenty":-42.460696,"median":-26.774017,"eighty":15.108565,"marketCap":5605739430},{"date":"2026-01-30","current":16.997806,"twenty":-42.298396,"median":9.072035,"eighty":15.139285,"marketCap":5759298713},{"date":"2026-02-06","current":16.349667,"twenty":-42.121898,"median":9.212264,"eighty":15.161285,"marketCap":5539692426},{"date":"2026-02-13","current":16.222964,"twenty":-41.959732,"median":9.350441,"eighty":15.201872,"marketCap":5496761874},{"date":"2026-02-20","current":15.594318,"twenty":-41.959732,"median":9.370022,"eighty":15.220786,"marketCap":5283760288},{"date":"2026-02-27","current":21.19121,"twenty":-41.959732,"median":9.407027,"eighty":15.261496,"marketCap":5121152471},{"date":"2026-03-06","current":19.549977,"twenty":-41.959732,"median":9.422608,"eighty":15.297588,"marketCap":4724525628},{"date":"2026-03-13","current":19.060366,"twenty":-41.959732,"median":9.46156,"eighty":15.319151,"marketCap":4606204175},{"date":"2026-03-20","current":19.584457,"twenty":-41.959732,"median":9.512199,"eighty":15.336854,"marketCap":4732858125},{"date":"2026-03-27","current":20.632639,"twenty":-41.959732,"median":9.570627,"eighty":15.412902,"marketCap":4986166025},{"date":"2026-04-02","current":24.112643,"twenty":-41.959732,"median":9.593999,"eighty":15.466036,"marketCap":5827157765},{"date":"2026-04-10","current":24.02321,"twenty":-41.959732,"median":9.664113,"eighty":15.524453,"marketCap":5805544912},{"date":"2026-04-17","current":23.228627,"twenty":-41.959732,"median":9.742018,"eighty":15.606447,"marketCap":5613523023},{"date":"2026-04-24","current":23.32838,"twenty":-41.959732,"median":11.418222,"eighty":15.661134,"marketCap":5637629667},{"date":"2026-05-01","current":23.19079,"twenty":-41.959732,"median":11.622713,"eighty":15.730243,"marketCap":5604379123},{"date":"2026-05-08","current":38.634911,"twenty":-41.959732,"median":11.940489,"eighty":15.814201,"marketCap":5900323567},{"date":"2026-05-15","current":41.8654,"twenty":-41.959732,"median":12.174,"eighty":15.879905,"marketCap":6393683956},{"date":"2026-05-22","current":40.326552,"twenty":-41.959732,"median":12.331299,"eighty":15.906771,"marketCap":6158671068},{"date":"2026-05-29","current":43.589783,"twenty":-41.964268,"median":12.423564,"eighty":15.957458,"marketCap":6657031731},{"date":"2026-06-05","current":47.344136,"twenty":-41.959732,"median":12.501813,"eighty":16.013817,"marketCap":7230396507},{"date":"2026-06-12","current":49.024864,"twenty":-41.898367,"median":12.572144,"eighty":16.034853,"marketCap":7487077250},{"date":"2026-06-18","current":48.577398,"twenty":-41.824976,"median":12.578191,"eighty":16.107352,"marketCap":7418740169},{"date":"2026-06-26","current":57.657693,"twenty":-41.817921,"median":12.645689,"eighty":16.158784,"marketCap":8805482883},{"date":"2026-07-02","current":56.446259,"twenty":-41.803329,"median":12.68891,"eighty":16.20592,"marketCap":8620472738},{"date":"2026-07-10","current":58.694506,"twenty":-41.535725,"median":12.773878,"eighty":16.314234,"marketCap":8963824900},{"date":"2026-07-17","current":56.686363,"twenty":-41.52535,"median":12.829717,"eighty":16.483549,"marketCap":8657141415},{"date":"2026-07-24","current":57.810486,"twenty":-41.508406,"median":12.912967,"eighty":16.53282,"marketCap":8828817496},{"date":"2026-07-31","current":126.933087,"twenty":-41.435384,"median":12.976145,"eighty":16.764866,"marketCap":8393196498},{"date":"2026-08-07","current":122.721435,"twenty":-41.179453,"median":13.089846,"eighty":17.012426,"marketCap":8114709466},{"date":"2026-08-14","current":125.461546,"twenty":-40.97486,"median":13.175122,"eighty":18.458256,"marketCap":8295893800},{"date":"2026-08-21","current":121.833436,"twenty":-40.812598,"median":13.242761,"eighty":18.732957,"marketCap":8055992321},{"date":"2026-08-28","current":124.066119,"twenty":-40.574229,"median":13.376086,"eighty":18.818872,"marketCap":8203624000},{"date":"2026-09-01","current":119.220183,"twenty":-40.481017,"median":13.431577,"eighty":18.870166,"marketCap":7883196151}],"updateTime":1788370895609},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALKS\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2643936249","title":"Alkermes (ALKS) Stock Valuation After New Orphan Drug Designation For Alixorexton","url":"https://stock-news.laohu8.com/highlight/detail?id=2643936249","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643936249?lang=en_us&edition=fundamental","pubTime":"2026-06-14 18:14","pubTimestamp":1781432056,"startTime":"0","endTime":"0","summary":"Why the new orphan drug designation matters for Alkermes (ALKS)\nThe latest catalyst for Alkermes (ALKS) is the US FDA orphan drug designation for alixorexton, its phase 2 oral treatment targeting idiopathic hypersomnia. This status brings specific regulatory incentives and renewed focus on the company’s rare disease pipeline.\nSee our latest analysis for Alkermes.\nAlkermes’ share price has moved sharply higher in recent months, with a 30 day share price return of 18.14% and a 90 day gain of...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-stock-valuation-after-new-orphan-drug-designat","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/alkermes-alks-stock-valuation-after-new-orphan-drug-designat","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","DCF","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2643163152","title":"Alkermes director Christopher I. Wright disposes of USD 90,200 in common shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2643163152","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2643163152?lang=en_us&edition=fundamental","pubTime":"2026-06-13 08:05","pubTimestamp":1781309102,"startTime":"0","endTime":"0","summary":"Alkermes director Christopher I. Wright sold 2,000 ordinary shares on June 12, 2026 at USD 45.1 each.Wright’s direct holding fell to 25,680 ordinary shares following the transaction.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 12, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260613:nNDL2zj6dZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes director Christopher I. Wright disposes of USD 90,200 in common shares","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642398922","title":"Should Alkermes’ (ALKS) Sleep-Medicine Pivot After Lumryz and Alixorexton Data Require Investor Action?","url":"https://stock-news.laohu8.com/highlight/detail?id=2642398922","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642398922?lang=en_us&edition=fundamental","pubTime":"2026-06-12 01:21","pubTimestamp":1781198506,"startTime":"0","endTime":"0","summary":"In early June 2026, Alkermes reported a narrower-than-expected first-quarter loss and stronger revenue, supported by higher sales of Vivitrol, Aristada, Lybalvi, and newly acquired Lumryz, while reaffirming its full-year revenue guidance despite increased R&D and acquisition-related spending.\nBy pairing solid proprietary product trends with encouraging new data for orexin agonist alixorexton, the company is increasingly framing sleep medicine as a core pillar of its evolving business...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/should-alkermes-alks-sleep-medicine-pivot-after-lumryz-and-a","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/should-alkermes-alks-sleep-medicine-pivot-after-lumryz-and-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642235481","title":"Alkermes’ alixorexton granted orphan designation for idiopathic hypersomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2642235481","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642235481?lang=en_us&edition=fundamental","pubTime":"2026-06-12 00:11","pubTimestamp":1781194302,"startTime":"0","endTime":"0","summary":"Alkermes (ALKS)’ alixorexton was granted FDA orphan designation as a treatment of idiopathic hypersomnia, according to a post to the agency’s websi...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-alixorexton-granted-orphan-designation-for-idiopathic-hypersomnia-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-alixorexton-granted-orphan-designation-for-idiopathic-hypersomnia-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LABU","ALKS","BK4585","BK4588","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642371418","title":"Mizuho Securities Sticks to Their Buy Rating for Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642371418","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642371418?lang=en_us&edition=fundamental","pubTime":"2026-06-10 05:35","pubTimestamp":1781040912,"startTime":"0","endTime":"0","summary":"In a report released today, Uy Ear from Mizuho Securities reiterated a Buy rating on Alkermes, with a price target of $53.00. According to TipRanks...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-alkermes-alks-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-sticks-to-their-buy-rating-for-alkermes-alks-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642496243","title":"Alkermes' Orexin May Have Applicability Outside Sleep, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2642496243","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642496243?lang=en_us&edition=fundamental","pubTime":"2026-06-09 23:32","pubTimestamp":1781019160,"startTime":"0","endTime":"0","summary":"Alkermes'  work on developing applications for orexin agonists outside of sleep indications can reposition the firm as a leader in the space, RBC Capital Markets said in a Monday note.As orexin in sleep become ever more crowded, the report said  interest in other applications build. RBC analysts project a 50/50 split across the base business and future pipeline.\"While there may be potential in at least 5 major disorders, we see the strongest support for ADHD and addiction,\" they said.Alkermes is studying orexin applications for ADHD and fatigue, with initial ADHD data expected in Q4, according to the note.\"We think near-term data catalysts for these programs can help investors reframe ALKS as a leader in the space,\" the note said.RBC raised its price target to $56 from $45 while maintaining its outperform rating.Price: 43.13, Change: +0.68, Percent Change: +1.61","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642643714","title":"RBC Raises Price Target on Alkermes to $56 From $45, Keeps Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2642643714","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642643714?lang=en_us&edition=fundamental","pubTime":"2026-06-09 18:57","pubTimestamp":1781002637,"startTime":"0","endTime":"0","summary":"Alkermes (ALKS) has an average rating of buy and mean price target of $46.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642593459","title":"Alkermes Plc : RBC Raises Target Price to $56 From $45","url":"https://stock-news.laohu8.com/highlight/detail?id=2642593459","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642593459?lang=en_us&edition=fundamental","pubTime":"2026-06-09 11:48","pubTimestamp":1780976939,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260609:nFWN42G10T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641485838","title":"Analysts Offer Insights on Healthcare Companies: Alkermes (ALKS) and Structure Therapeutics, Inc. Sponsored ADR (GPCR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641485838","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641485838?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:20","pubTimestamp":1780914051,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alkermes (ALKS) and Structure Therapeutics, Inc. Spo...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-alkermes-alks-and-structure-therapeutics-inc-sponsored-adr-gpcr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4599","LABU","XBI","BK4585","BK4588","BK4007","BK4137","XLV","LU0029874061.USD","BK4139","GPCR","BK4581","LU0128526141.USD","HCSG","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641967911","title":"A Look At Alkermes (ALKS) Valuation After 28.2% Revenue Growth And Strengthening Analyst Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2641967911","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641967911?lang=en_us&edition=fundamental","pubTime":"2026-06-05 09:29","pubTimestamp":1780622962,"startTime":"0","endTime":"0","summary":"Why Alkermes Stock Is Back on Investors’ Radar\nAlkermes (ALKS) has drawn fresh attention after reporting 28.2% revenue growth, alongside upbeat analyst commentary on its treatments for addiction, schizophrenia, bipolar I disorder, and neurological conditions.\nThat backdrop, together with executive stock transactions and a scheduled appearance at a major healthcare investor conference, provides several new data points to consider if you are tracking Alkermes stock.\nSee our latest analysis for...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/a-look-at-alkermes-alks-valuation-after-282-revenue-growth-a","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/a-look-at-alkermes-alks-valuation-after-282-revenue-growth-a","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641167450","title":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $87,569.7","url":"https://stock-news.laohu8.com/highlight/detail?id=2641167450","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641167450?lang=en_us&edition=fundamental","pubTime":"2026-06-05 05:00","pubTimestamp":1780606854,"startTime":"0","endTime":"0","summary":"Alkermes EVP and chief legal officer David Joseph Gaffin sold 2,034 ordinary shares on June 4, 2026 at $43.05.Gaffin held 229,524 ordinary shares following the sale.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 04, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDL1cX68f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Alkermes EVP, CLO David Joseph Gaffin sells 2,034 shares for $87,569.7","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640415417","title":"Alkermes to present new data on Alixorexton, LUMRYZ","url":"https://stock-news.laohu8.com/highlight/detail?id=2640415417","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640415417?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:11","pubTimestamp":1780571466,"startTime":"0","endTime":"0","summary":"Alkermes (ALKS) announced plans to present new data from its industry-leading portfolio of sleep medicine research at SLEEP 2026, the 40th annual m...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/alkermes-to-present-new-data-on-alixorexton-lumryz-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/alkermes-to-present-new-data-on-alixorexton-lumryz-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640151069","title":"Alkermes presents new phase 2 Vibrance-2 data for alixorexton in narcolepsy type 2 at SLEEP 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2640151069","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640151069?lang=en_us&edition=fundamental","pubTime":"2026-06-04 19:01","pubTimestamp":1780570878,"startTime":"0","endTime":"0","summary":"Alkermes outlined plans to present new clinical data at the SLEEP 2026 meeting in Baltimore on June 14-17, 2026.Detailed results from the Phase 2 Vibrance-2 trial of alixorexton in narcolepsy type 2 will be presented in a June 17 oral session.The company flagged positive outcomes from Vibrance-2, positioning the program as supportive of continued late-stage development in narcolepsy.Additional presentations will cover Phase 3 trial designs for alixorexton in narcolepsy and new analyses on LUMRYZ, including real-world experience and idiopathic hypersomnia work.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via Business Wire  on June 04, 2026, and is solely res","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260604:nNDLc7PWGY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640318797","title":"Mizuho Securities Reaffirms Their Buy Rating on Alkermes (ALKS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640318797","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640318797?lang=en_us&edition=fundamental","pubTime":"2026-06-04 06:35","pubTimestamp":1780526141,"startTime":"0","endTime":"0","summary":"Mizuho Securities analyst Uy Ear reiterated a Buy rating on Alkermes today and set a price target of $53.00. Ear covers the Healthcare sector, focu...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/mizuho-securities-reaffirms-their-buy-rating-on-alkermes-alks-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MFG","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640118181","title":"Alkermes to join Goldman Sachs Global Healthcare Conference fireside chat","url":"https://stock-news.laohu8.com/highlight/detail?id=2640118181","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640118181?lang=en_us&edition=fundamental","pubTime":"2026-06-04 04:06","pubTimestamp":1780517169,"startTime":"0","endTime":"0","summary":"Alkermes will join a fireside chat at the Goldman Sachs 47th Annual Global Healthcare Conference on June 10, 2026.The session is scheduled for 10:00 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via Business Wire  on June 03, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL8QsXRz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2471134523.USD","BK4516","LU0942090050.USD","LU1868836757.USD","LU1868836591.USD","LU0048573561.USD","LU2471134879.HKD","IE00B19Z3581.USD","BK4533","LU0251142724.SGD","LU1868837300.USD","LU0251131958.USD","LU0345770308.USD","IE00BFXG1179.USD","LU0345770993.USD","LU2237443895.HKD","LU0868494708.USD","LU2237443978.SGD","LU2471134796.USD","LU1894683348.USD","BK4504","GSX","IE00B19Z3B42.SGD","LU2750360997.AUD","LU1868836914.USD","LU2237443549.SGD","BK4139","GS","LU0742534661.SGD","LU1668664300.SGD","LU0061475181.USD","LU2237443622.USD","LU1804176565.USD","LU2265009873.SGD","BK4550","BK4585","IE0002270589.USD","LU0868494617.USD","BK4552","LU1791807156.HKD","LU0106831901.USD","LU1894683264.USD","LU2237443382.USD","ALKS","LU2237438978.USD","LU2750360641.GBP","BK4588","LU0096364046.USD","LU2237443465.HKD","IE00BSNM7G36.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640409947","title":"Is Alkermes’ (ALKS) New LYBALVI Real-World Data Quietly Reframing Its Psychiatry Investment Story?","url":"https://stock-news.laohu8.com/highlight/detail?id=2640409947","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640409947?lang=en_us&edition=fundamental","pubTime":"2026-06-03 01:23","pubTimestamp":1780420999,"startTime":"0","endTime":"0","summary":"In May 2026, Alkermes plc reported that it had presented new clinical and real-world evidence on its psychiatry portfolio, LYBALVI and ARISTADA, alongside sleep-medicine research across major U.S. psychiatric and health economics conferences, including APA, ISPOR, and others.\nA particularly important angle is Alkermes’ focus on real-world outcomes such as adherence, relapse proxies, and acute care use, which can influence how clinicians and payers view the practical value of LYBALVI versus...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/is-alkermes-alks-new-lybalvi-real-world-data-quietly-reframi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alks/alkermes/news/is-alkermes-alks-new-lybalvi-real-world-data-quietly-reframi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640960047","title":"Alkermes Chief Medical Officer Craig Hopkinson sells 9,000 shares for $375,044‬","url":"https://stock-news.laohu8.com/highlight/detail?id=2640960047","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640960047?lang=en_us&edition=fundamental","pubTime":"2026-06-02 07:27","pubTimestamp":1780356444,"startTime":"0","endTime":"0","summary":"Alkermes EVP R&D and Chief Medical Officer Craig C. Hopkinson exercised options for 5,000 ordinary shares at $19.34 on June 1.Hopkinson sold 9,000 ordinary shares at an average price of $41.67 on the same day.Directly owned ordinary shares fell to 77,389 following the transactions.Employee stock options held rose to 6,356 after the exercise.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 01, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLb446MD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alkermes Chief Medical Officer Craig Hopkinson sells 9,000 shares for $375,044‬","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639670215","title":"Alkermes VP Finance Samuel Joseph Parisi disposes of 16,217 shares for $686,807.86","url":"https://stock-news.laohu8.com/highlight/detail?id=2639670215","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639670215?lang=en_us&edition=fundamental","pubTime":"2026-05-30 06:03","pubTimestamp":1780092231,"startTime":"0","endTime":"0","summary":"Alkermes VP, Finance  Samuel Joseph Parisi sold 16,217 ordinary shares on May 29, 2026 at USD 42.36.Parisi exercised employee stock options for 16,217 ordinary shares at USD 19.34 to USD 20.03.He reported direct ownership of 7,717 ordinary shares following the transactions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alkermes plc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on May 29, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDL8xQvtn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Alkermes VP Finance Samuel Joseph Parisi disposes of 16,217 shares for $686,807.86","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALKS","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639493614","title":"Needham Reiterates Buy Rating on Alkermes as Preclinical ALKS 7290 Data Support Unchanged $50 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2639493614","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639493614?lang=en_us&edition=fundamental","pubTime":"2026-05-29 06:45","pubTimestamp":1780008320,"startTime":"0","endTime":"0","summary":"Ami Fadia, an analyst from Needham, maintained the Buy rating on Alkermes. The associated price target remains the same with $50.00. Ami Fadia has ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/needham-reiterates-buy-rating-on-alkermes-as-preclinical-alks-7290-data-support-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/needham-reiterates-buy-rating-on-alkermes-as-preclinical-alks-7290-data-support-unchanged-50-price-target-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638516920","title":"Alkermes presents Phase 2 Vibrance-1 data on alixorexton in narcolepsy type 1 at ASCP meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2638516920","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2638516920?lang=en_us&edition=fundamental","pubTime":"2026-05-26 19:01","pubTimestamp":1779793282,"startTime":"0","endTime":"0","summary":"Alkermes set 11 poster presentations for the ASCP annual meeting in Miami on May 26-29, 2026; results will be presented in the future.New Phase 2 Vibrance-1 posters on alixorexton in narcolepsy type 1 are slated to highlight patient-reported improvements in disease severity, fatigue, cognitive functioning.Additional posters are expected to support the strategic rationale for orexin 2 receptor agonists across sleep-wake disturbance, fatigue, cognitive deficits in neuropsychiatric disease.Real-world analyses of LYBALVI and ARISTADA are scheduled to address persistence, adherence, relapse, inpatient initiation in schizophrenia, with implications for commercial positioning.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260526:nNDLbSYFKf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ALKS"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":9,"pageCount":5,"totalSize":171,"code":"91000000","status":"200"}]}}